ST13, Hsp70 interacting protein pseudogene 18Genealiases: []
Q-omics provides the consensus-scored ST13P18 profile across patient tissues and cancer cell-line models. ST13P18 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, ST13P18 is differentially expressed in 10, with the highest sampling consensus in KIRP. Additionally, ST13P18 RNA expression shows 15,487 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight LUAD, KIRP, and ACC as cancer lineages where ST13P18 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ST13P18 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ST13P18 survival associations across molecular data types. ST13P18 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ST13P18 RNA expression–survival associations across cancer types. High ST13P18 expression shows unfavorable associations in LUAD and ACC, but favorable associations in KIRC, THCA, CESC and KIRP. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .005). Together, the overview and detailed table identify LUAD as the clearest survival context for ST13P18 RNA expression.
This table summarizes ST13P18 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for ST13P18. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ST13P18 shows lower tumor expression in KIRP, THCA and UCEC and higher tumor expression in CHOL, LUSC and LIHC. The KIRP box plot shows higher ST13P18 RNA expression in normal versus tumor tissue (log2 FC = −0.401, t-test p = .007).
This table shows molecular features associated with ST13P18 in patient tissues and cancer cell lines. In patient samples, ST13P18 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
